Physician profile
James T Sutton
NPI 1043215635
$493.08
in general payments reported to CMS, 2019-2025
11 companies · $88.78 in 2025
The $88.78 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2022: $13.99 · 2023: $59.35 · 2024: $180 · 2025: $88.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $128.40 | 2022-2024 | Abre, Micra |
| Baxter Healthcare | $118.78 | 2019 | |
| Zimmer Biomet Holdings, INC. | $61.44 | 2025 | Persona |
| Cvrx, INC. | $48.86 | 2023-2024 | Barostim Neo System |
| Biosense Webster, INC. | $27.34 | 2025 | Carto 3 |
| Acera Surgical, INC. | $23.80 | 2024 | Restrata Wound Matrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.40 | 2023 | Lifevest |
| Focal Therapeutics, INC. | $17.56 | 2019 | |
| Boston Scientific Corporation | $16.88 | 2023 | Varithena Administration Pack |
| Bolder Surgical LLC | $14.96 | 2019 | |
| Esperion Therapeutics, INC. | $14.66 | 2024 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.